APO RESEARCH · REPORT
Human Growth Hormone
Growth hormone (GH), also known as somatotropin (or as human growth hormone in its human form), is a peptide hormone that stimulates growth, cell reproduction, and cell regeneration in humans and other animals. It is thus important in human development. It is a type of mitogen which is specific only to certain kinds of cells. Growth hormone is a 191-amino acid, single-chain polypeptide that is synthesized, stored, and secreted by somatotropic cells within the lateral wings of the anterior pituitary gland.
Product & engineering
Understand the product.
Growth hormone (GH), also known as somatotropin (or as human growth hormone in its human form), is a peptide hormone that stimulates growth, cell reproduction, and cell regeneration in humans and other animals. It is thus important in human development. It is a type of mitogen which is specific only to certain kinds of cells. Growth hormone is a 191-amino acid, single-chain polypeptide that is synthesized, stored, and secreted by somatotropic cells within the lateral wings of the anterior pituitary gland.
Selected research
Market Structure
Global Human Growth Hormone Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Growth hormone (GH), also known as somatotropin (or as human growth hormone in its human form), is a peptide hormone that stimulates growth, cell reproduction, and cell regeneration in humans and other animals. It is thus important in human development. It is a type of mitogen which is specific only to certain kinds of cells. Growth hormone is a 191-amino acid, single-chain polypeptide that is synthesized, stored, and secreted by somatotropic cells within the lateral wings of the anterior pituitary gland.
For industry structure analysis, the Human Growth Hormone industry is very concentrated. These manufacturers ranging from large multinational corporations to small privately owned companies compete in this industry. The top five producers include Novo Nordisk, Pfizer, Eli Lilly, Merck Serono and F. Hoffmann-La Roche, account for more than 80% of the revenue market. Regionally, North America is the biggest production value area of valves, also the leader in the whole Human Growth Hormone industry.
North America occupied 42% of the production market. It is followed by Europe and China, which respectively have around 27% and 16% of the global total industry. Other countries have a small amount of production. Geographically, North America was the largest consumption market in the world, which took about 44.59% of the global consumption volume.
Read the full market overview
This report provides an overview of the global Human Growth Hormone market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Human Growth Hormone and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Human Growth Hormone sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Human Growth Hormone market size, projected growth trends, production technologies, key applications, and end-use industries.
Human Growth Hormone Segment by Company
Novo Nordisk
Pfizer
Eli Lilly
Merck Serono
F. Hoffmann-La Roche
Ferring Pharmaceuticals
GeneScience Pharmaceuticals
Ipsen
LG Life Sciences
Sandoz International
Anhui Anke Biotechnology
Human Growth Hormone Segment by Type
Powder
Solvent
Human Growth Hormone Segment by Application
Growth Hormone Deficiency (GHD)
Turner Syndrome
Chronic Renal Insufficiency
Prader Willi Syndrome
Small for Gestational Age
SHOX Deficiency
Others
Human Growth Hormone Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Growth Hormone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Human Growth Hormone and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Growth Hormone.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Human Growth Hormone market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Human Growth Hormone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Human Growth Hormone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Human Growth Hormone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Powder
- Solvent
Applications
- Growth Hormone Deficiency (GHD)
- Turner Syndrome
- Chronic Renal Insufficiency
- Prader Willi Syndrome
- Small for Gestational Age
- SHOX Deficiency
- Others
Companies covered
- Novo Nordisk
- Pfizer
- Eli Lilly
- Merck Serono
- F. Hoffmann-La Roche
- Ferring Pharmaceuticals
- GeneScience Pharmaceuticals
- Ipsen
- LG Life Sciences
- Sandoz International
- Anhui Anke Biotechnology
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Human Growth Hormone Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Human Growth Hormone Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Human Growth Hormone Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Human Growth Hormone Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Human Growth Hormone Market Dynamics
- 2.1 Human Growth Hormone Industry Trends
- 2.2 Human Growth Hormone Industry Drivers
- 2.3 Human Growth Hormone Industry Opportunities and Challenges
- 2.4 Human Growth Hormone Industry Restraints
3 Human Growth Hormone Market by Manufacturers
- 3.1 Global Human Growth Hormone Revenue by Manufacturers (2021-2026)
- 3.2 Global Human Growth Hormone Sales by Manufacturers (2021-2026)
- 3.3 Global Human Growth Hormone Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Human Growth Hormone Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Human Growth Hormone Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Human Growth Hormone Manufacturers, Product Type & Application
- 3.7 Global Human Growth Hormone Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Human Growth Hormone Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Human Growth Hormone Players Market Share by Revenue in 2025
- 3.8.3 2025 Human Growth Hormone Tier 1, Tier 2, and Tier 3
4 Human Growth Hormone Market by Type
- 4.1 Human Growth Hormone Type Introduction
- 4.1.1 Powder
- 4.1.2 Solvent
- 4.2 Global Human Growth Hormone Sales by Type
- 4.2.1 Global Human Growth Hormone Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Human Growth Hormone Sales by Type (2021-2032)
- 4.2.3 Global Human Growth Hormone Sales Market Share by Type (2021-2032)
- 4.3 Global Human Growth Hormone Revenue by Type
- 4.3.1 Global Human Growth Hormone Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Human Growth Hormone Revenue by Type (2021-2032)
- 4.3.3 Global Human Growth Hormone Revenue Market Share by Type (2021-2032)
5 Human Growth Hormone Market by Application
- 5.1 Human Growth Hormone Application Introduction
- 5.1.1 Growth Hormone Deficiency (GHD)
- 5.1.2 Turner Syndrome
- 5.1.3 Chronic Renal Insufficiency
- 5.1.4 Prader Willi Syndrome
- 5.1.5 Small for Gestational Age
- 5.1.6 SHOX Deficiency
- 5.1.7 Others
- 5.2 Global Human Growth Hormone Sales by Application
- 5.2.1 Global Human Growth Hormone Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Human Growth Hormone Sales by Application (2021-2032)
- 5.2.3 Global Human Growth Hormone Sales Market Share by Application (2021-2032)
- 5.3 Global Human Growth Hormone Revenue by Application
- 5.3.1 Global Human Growth Hormone Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Human Growth Hormone Revenue by Application (2021-2032)
- 5.3.3 Global Human Growth Hormone Revenue Market Share by Application (2021-2032)
6 Global Human Growth Hormone Sales by Region
- 6.1 Global Human Growth Hormone Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Human Growth Hormone Sales by Region (2021-2032)
- 6.2.1 Global Human Growth Hormone Sales by Region (2021-2026)
- 6.2.2 Global Human Growth Hormone Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Human Growth Hormone Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Human Growth Hormone Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Human Growth Hormone Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Human Growth Hormone Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Human Growth Hormone Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Human Growth Hormone Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Human Growth Hormone Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Human Growth Hormone Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Human Growth Hormone Revenue by Region
- 7.1 Global Human Growth Hormone Revenue by Region
- 7.1.1 Global Human Growth Hormone Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Human Growth Hormone Revenue by Region (2021-2026)
- 7.1.3 Global Human Growth Hormone Revenue by Region (2027-2032)
- 7.1.4 Global Human Growth Hormone Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Human Growth Hormone Revenue (2021-2032)
- 7.2.2 North America Human Growth Hormone Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Human Growth Hormone Revenue (2021-2032)
- 7.3.2 Europe Human Growth Hormone Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Human Growth Hormone Revenue (2021-2032)
- 7.4.2 Asia-Pacific Human Growth Hormone Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Human Growth Hormone Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Human Growth Hormone Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Novo Nordisk
- 8.1.1 Novo Nordisk Company Information
- 8.1.2 Novo Nordisk Business Overview
- 8.1.3 Novo Nordisk Human Growth Hormone Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Novo Nordisk Human Growth Hormone Product Portfolio
- 8.1.5 Novo Nordisk Recent Developments
- 8.2 Pfizer
- 8.2.1 Pfizer Company Information
- 8.2.2 Pfizer Business Overview
- 8.2.3 Pfizer Human Growth Hormone Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Pfizer Human Growth Hormone Product Portfolio
- 8.2.5 Pfizer Recent Developments
- 8.3 Eli Lilly
- 8.3.1 Eli Lilly Company Information
- 8.3.2 Eli Lilly Business Overview
- 8.3.3 Eli Lilly Human Growth Hormone Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Eli Lilly Human Growth Hormone Product Portfolio
- 8.3.5 Eli Lilly Recent Developments
- 8.4 Merck Serono
- 8.4.1 Merck Serono Company Information
- 8.4.2 Merck Serono Business Overview
- 8.4.3 Merck Serono Human Growth Hormone Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Merck Serono Human Growth Hormone Product Portfolio
- 8.4.5 Merck Serono Recent Developments
- 8.5 F. Hoffmann-La Roche
- 8.5.1 F. Hoffmann-La Roche Company Information
- 8.5.2 F. Hoffmann-La Roche Business Overview
- 8.5.3 F. Hoffmann-La Roche Human Growth Hormone Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 F. Hoffmann-La Roche Human Growth Hormone Product Portfolio
- 8.5.5 F. Hoffmann-La Roche Recent Developments
- 8.6 Ferring Pharmaceuticals
- 8.6.1 Ferring Pharmaceuticals Company Information
- 8.6.2 Ferring Pharmaceuticals Business Overview
- 8.6.3 Ferring Pharmaceuticals Human Growth Hormone Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Ferring Pharmaceuticals Human Growth Hormone Product Portfolio
- 8.6.5 Ferring Pharmaceuticals Recent Developments
- 8.7 GeneScience Pharmaceuticals
- 8.7.1 GeneScience Pharmaceuticals Company Information
- 8.7.2 GeneScience Pharmaceuticals Business Overview
- 8.7.3 GeneScience Pharmaceuticals Human Growth Hormone Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 GeneScience Pharmaceuticals Human Growth Hormone Product Portfolio
- 8.7.5 GeneScience Pharmaceuticals Recent Developments
- 8.8 Ipsen
- 8.8.1 Ipsen Company Information
- 8.8.2 Ipsen Business Overview
- 8.8.3 Ipsen Human Growth Hormone Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Ipsen Human Growth Hormone Product Portfolio
- 8.8.5 Ipsen Recent Developments
- 8.9 LG Life Sciences
- 8.9.1 LG Life Sciences Company Information
- 8.9.2 LG Life Sciences Business Overview
- 8.9.3 LG Life Sciences Human Growth Hormone Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 LG Life Sciences Human Growth Hormone Product Portfolio
- 8.9.5 LG Life Sciences Recent Developments
- 8.10 Sandoz International
- 8.10.1 Sandoz International Company Information
- 8.10.2 Sandoz International Business Overview
- 8.10.3 Sandoz International Human Growth Hormone Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Sandoz International Human Growth Hormone Product Portfolio
- 8.10.5 Sandoz International Recent Developments
- 8.11 Anhui Anke Biotechnology
- 8.11.1 Anhui Anke Biotechnology Company Information
- 8.11.2 Anhui Anke Biotechnology Business Overview
- 8.11.3 Anhui Anke Biotechnology Human Growth Hormone Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Anhui Anke Biotechnology Human Growth Hormone Product Portfolio
- 8.11.5 Anhui Anke Biotechnology Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Human Growth Hormone Value Chain Analysis
- 9.1.1 Human Growth Hormone Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Human Growth Hormone Production Mode & Process
- 9.2 Human Growth Hormone Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Human Growth Hormone Distributors
- 9.2.3 Human Growth Hormone Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst